As of December 2024 Strides Pharma has a market cap of NZ$1.31 Billion. This makes Strides Pharma the world's 6017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2024 | NZ$1.31 B | 16.18% |
2023 | NZ$1.13 B | 88.6% |
2022 | NZ$0.60 B | -23.82% |
2021 | NZ$0.78 B | -47.08% |
2020 | NZ$1.49 B | 121.03% |
2019 | NZ$0.67 B | -23.32% |
2018 | NZ$0.88 B | -45.63% |
2017 | NZ$1.61 B | -19.73% |
2016 | NZ$2.01 B | 19.32% |
2015 | NZ$1.69 B | 46.78% |
2014 | NZ$1.15 B | 176.01% |
2013 | NZ$0.41 B | -70.84% |
2012 | NZ$1.43 B | 152.68% |
2011 | NZ$0.56 B | -24.44% |
2010 | NZ$0.74 B | 162.63% |
2009 | NZ$0.28 B | 122.39% |
2008 | NZ$0.12 B | -61.14% |
2007 | NZ$0.33 B | -20.09% |
2006 | NZ$0.41 B | 17.62% |
2005 | NZ$0.35 B |